Immedica wins accelerated approval for once-rejected rare disease drugnews2026-02-24T14:18:23+00:00February 24th, 2026|Endpoints News|
New biotech Slate Medicines raises $130M for migraine drug from Chinanews2026-02-24T12:30:21+00:00February 24th, 2026|Endpoints News|
AI biotech Turbine raises $25M Series B to sell ‘Virtual Lab’ to pharmanews2026-02-24T12:00:54+00:00February 24th, 2026|Endpoints News|
Novo Nordisk’s triple-G is competitive with Lilly in obesity, but likely to be second to marketnews2026-02-24T11:37:17+00:00February 24th, 2026|Endpoints News|
